What the U.S. can learn from India's rapid coronavirus testing efforts

India scaled up its coronavirus testing over a two-month period starting in June by relying on faster, cheaper antigen tests. At first glance, that's a positive development and a strategy the United States is also considering as the pandemic continues, The Associated Press reports. At the same time, however, there's a sense that India has become overly reliant on the antigen tests, which are also less accurate than slower, more expensive lab tests.
The problem isn't the antigen tests themselves since their shortcomings are well understood. Rather, India seemingly hasn't been retesting enough patients who have tested negative even though the country's health officials are recommending the practice, particularly for those who have symptoms. Between June 18 and July 29, court documents reportedly show that in Delhi state only 0.5 percent, or 1,365 of the more than 260,000 people who tested negative, were retested. Plus, there's been a decline in use of more precise lab tests, the figure falling from 11,000 per day to just 5,400.
Dr. Ashish Jha, director of Harvard University's Global Health Institute, said combining data from the two types of tests shouldn't be used to determine that infections are going down in India since using less accurate tests will automatically drive the numbers south, especially if retesting is limited. Going forward, large countries struggling with outbreaks like the U.S. and India will likely need to strike a balance between speed and precision by continuing to rely on accurate lab tests and get retested regularly when using antigen tests. Read more at The Associated Press.
Subscribe to The Week
Escape your echo chamber. Get the facts behind the news, plus analysis from multiple perspectives.

Sign up for The Week's Free Newsletters
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
Sign up for Today's Best Articles in your inbox
A free daily email with the biggest news stories of the day – and the best features from TheWeek.com
Tim is a staff writer at The Week and has contributed to Bedford and Bowery and The New York Transatlantic. He is a graduate of Occidental College and NYU's journalism school. Tim enjoys writing about baseball, Europe, and extinct megafauna. He lives in New York City.
-
5 exclusive cartoons about Trump and Putin negotiating peace
Cartoons Artists take on alternative timelines, missing participants, and more
By The Week US Published
-
The AI arms race
Talking Point The fixation on AI-powered economic growth risks drowning out concerns around the technology which have yet to be resolved
By The Week UK Published
-
Why Jannik Sinner's ban has divided the tennis world
In the Spotlight The timing of the suspension handed down to the world's best male tennis player has been met with scepticism
By The Week UK Published
-
Ozempic can curb alcohol cravings, study finds
Speed read Weight loss drugs like Ozempic and Wegovy may also be helpful in limiting alcohol consumption
By Peter Weber, The Week US Published
-
New form of H5N1 bird flu found in US dairy cows
Speed Read This new form of bird flu is different from the version that spread through herds in the last year
By Peter Weber, The Week US Published
-
Microplastics accumulating in human brains, study finds
Speed Read The amount of tiny plastic particles found in human brains increased dramatically from 2016 to 2024
By Peter Weber, The Week US Published
-
FDA approves painkiller said to thwart addiction
Speed Read Suzetrigine, being sold as Journavx, is the first new pharmaceutical pain treatment approved by the FDA in 20 years
By Rafi Schwartz, The Week US Published
-
Study finds possible alternative abortion pill
Speed Read An emergency contraception (morning-after) pill called Ella could be an alternative to mifepristone for abortions
By Peter Weber, The Week US Published
-
California declares bird flu emergency
Speed Read The emergency came hours after the nation's first person with severe bird flu infection was hospitalized
By Rafi Schwartz, The Week US Published
-
Bird flu one mutuation from human threat, study finds
Speed Read A Scripps Research Institute study found one genetic tweak of the virus could enable its spread among people
By Peter Weber, The Week US Published
-
Dark chocolate tied to lower diabetes risk
Speed Read The findings were based on the diets of about 192,000 US adults over 34 years
By Peter Weber, The Week US Published